P.1.030 Double-blind, placebo-controlled,multicenter study evaluating nemifitide, a new pentapeptide antidepressant, when given daily or every other day for three weeks in the treatment of major depressive disorder

2005 ◽  
Vol 15 ◽  
pp. S119
Author(s):  
J.P. Feighner ◽  
L. Sverdlov ◽  
J. Hlavka ◽  
G. Nicolau ◽  
G. Tonelli ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Multicenter Study ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder

2018 ◽  
Vol 6 (5) ◽  
pp. 1604-1612 ◽  
Author(s):  
E. Sherwood Brown ◽  
Nasreen Sayed ◽  
Erin Van Enkevort ◽  
Alexandra Kulikova ◽  
Alyson Nakamura ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo

A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder

2013 ◽  
Vol 74 (07) ◽  
pp. e636-e641 ◽  
Author(s):  
Cristina Cusin ◽  
Nadia Iovieno ◽  
Dan V. Iosifescu ◽  
Andrew A. Nierenberg ◽  
Maurizio Fava ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Treatment Resistant ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document